GT Apeiron Therapeutics
About:
GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology.
Website: https://www.apeiron-bio.com
Top Investors: GT Healthcare Capital Partners, Viva BioInnovator, Panacea Venture
Description:
GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology. The company develops breakthrough investigational medicines by harnessing the power of artificial intelligence, aiming to drastically increase efficiency throughout the drug discovery process.
Total Funding Amount:
$44.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2019-01-01
Founders:
Alan Au
Number of Employees:
11-50
Last Funding Date:
2022-03-29
IPO Status:
Private
© 2024 MyAiNote.com